Deep learning strategy for cost-effective, comprehensive cardiac screening from ECG alone, by transferring domain-specific structural information from cardiac magnetic resonance (CMR) imaging into ECG representations. Combines multimodal contrastive learning with masked data modelling during pretraining on paired ECG-CMR data, then uses only ECG at inference. On 40,044 UK Biobank subjects, the multimodal pretraining improved subject-specific CVD risk prediction by up to 12.19% and cardiac phenotype prediction by up to 27.59% versus ECG-only baselines, with learned ECG representations shown to incorporate information from CMR regions of interest.

Self-supervised deep learning model that extracts cardiovascular-risk-relevant patterns from multimodal polysomnography (PSG) signals -- EEG, ECG, and respiratory signals -- without relying on manual sleep-stage annotations. Trained on 4,398 participants, the model derives 'projection scores' by contrasting embeddings from individuals with and without cardiovascular disease (CVD) outcomes. Externally validated in an independent cohort of 1,093 participants, ECG-derived projection scores were predictive of prevalent and incident cardiac conditions (particularly CVD mortality), and combining projection scores with the Framingham Risk Score consistently improved prediction (AUC 0.607-0.965 internally, 0.710-0.807 externally across most outcomes).

Regression-based convolutional neural network that directly estimates the heart-rate-corrected QT interval (QTc) from a 12-lead ECG, aiming to improve on automated QTc measurements from commercial ECG systems, which often diverge from expert readings. QTcNet was trained on 120,300 algorithm-labeled ECGs from an internal hospital cohort and the public MIMIC-IV database (after correcting for a vendor-specific measurement bias), and evaluated against expert QTc measurements in three independent external cohorts (PTB Diagnostic ECG Database, QTcMS, and ECGRDVQ). It roughly halved the mean absolute error compared with standard ECG analysis software (from 23.4ms to 13.4ms across external validation cohorts), with explainability analysis confirming the model focuses on physiologically plausible QRS-onset and T-offset regions.

Deep learning model that non-invasively estimates cardiac output (CO) from wearable seismocardiography (SCG), a single-lead ECG, and body mass index (BMI), as a potential alternative to invasive right heart catheterization (RHC). Parallel 1D-CNN branches extract features from the SCG and ECG waveforms, which are fused with BMI and passed through a lightweight regression head to predict CO directly. Trained and evaluated via leave-pair-out cross-validation on 73 heart-failure patients (83 RHC encounters) from an open PhysioNet dataset, the model achieved an RMSE of 1.00 L/min (22%) and Pearson correlation of 0.75 versus catheterization-derived CO, with particularly strong performance in low-output states.

Multi-outcome AI-ECG risk-estimation platform that turns a single 12-lead ECG into a patient-specific survival curve, using a residual convolutional neural network trained with a discrete-time survival loss to predict not just risk but time-to-event. Beyond all-cause and cardiovascular mortality, separately fine-tuned heads predict future ventricular arrhythmia, complete heart block, atrial fibrillation, atherosclerotic cardiovascular disease, heart failure, and (in follow-up work) hypertension -- all from a single resting ECG, including in ECGs a cardiologist would read as normal. Derived on 1.16 million ECGs from 189,539 Beth Israel Deaconess Medical Center patients and externally validated across transnational cohorts in the USA, Brazil (CODE), and the UK (UK Biobank). A variational autoencoder and genome/phenome-wide association analyses were used to show the model's predictions track biologically plausible features (QRS morphology, LV structure/function, and loci linked to cardiac structure, QT interval, and biological aging). NHS trials of AIRE were planned for late 2025. No public code or model weights have been released.

Multimodal cardiac-sensing foundation model pretrained with generative masked pretraining on ECG, PPG, and paired clinical/machine-generated text reports from roughly 1.7 million individuals across three large-scale critical-care and outpatient ECG datasets. A channel-embedding scheme lets the same model accept any combination of 12-lead ECG, single-lead/wearable ECG, and PPG. The resulting embeddings transfer to diagnostic classification, demographic recognition, vital-sign measurement, clinical-outcome prediction, and ECG question answering. Pretrained weights require a signed academic-access agreement rather than an open download.

1D residual neural network that predicts a patient's age directly from a 12-lead ECG; the gap between this predicted 'ECG age' and true chronological age is used as a biomarker of cardiovascular risk and mortality. Trained on the CODE-15% Brazilian ECG dataset, with the original R² of 0.71 later reproduced (R² = 0.70) in an independent German validation cohort. Developed by researchers at Uppsala University and UFMG.